There are over 100 vaccine candidates in the world — two in India have developed a vaccine, including Bharat Biotech in collaboration with ICMR, and Cadila Healthcare. Both have completed animal toxicity study and got nod to move ahead with Phase 1 and 2 trials.
“We want to fast-track the vaccine. We should not miss the bus. A vaccine after two years will not be of any use. This was the spirit behind the letter,” said Nivedita Gupta, scientist, ICMR.
The health ministry
is also in touch with the World Health Organization on the evolving evidence on the airborne nature of Covid-19. “We have been asking people to adopt Covid-appropriate behaviour... it is a dynamic situation and we will also refine our response, as as scientific evidence comes to fore,” said Bhushan.
On the Massachusetts Institute of Technology’s latest model that has predicted India could see over 287,000 cases per day by 2021 if no vaccine or treatment becomes available, Bhushan said the mathematical models do not take into account the efforts and interventions taken by governments and communities.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.